These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8342120)

  • 41. Organ blood flow after partial hepatectomy in rats: modification by endotoxin-neutralizing bactericidal/permeability-increasing protein (rBPI23).
    Boermeester MA; Houdijk AP; Straatsburg IH; van Noorden CJ; van Leeuwen PA
    J Hepatol; 1999 Nov; 31(5):905-12. PubMed ID: 10580589
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective effects of a recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in an animal model of gram-negative sepsis.
    Evans TJ; Carpenter A; Moyes D; Martin R; Cohen J
    J Infect Dis; 1995 Jan; 171(1):153-60. PubMed ID: 7798655
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of the structural elements in lipid A required for binding of a recombinant fragment of bactericidal/permeability-increasing protein rBPI23.
    Gazzano-Santoro H; Parent JB; Conlon PJ; Kasler HG; Tsai CM; Lill-Elghanian DA; Hollingsworth RI
    Infect Immun; 1995 Jun; 63(6):2201-5. PubMed ID: 7768599
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathogenesis of hemorrhage-induced bacteria/endotoxin translocation in rats. Effects of recombinant bactericidal/permeability-increasing protein.
    Yao YM; Bahrami S; Leichtfried G; Redl H; Schlag G
    Ann Surg; 1995 Apr; 221(4):398-405. PubMed ID: 7726676
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synergistic effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein and cefamandole in treatment of rabbit gram-negative sepsis.
    Lin Y; Leach WJ; Ammons WS
    Antimicrob Agents Chemother; 1996 Jan; 40(1):65-9. PubMed ID: 8787881
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protective effects of a recombinant N-terminal fragment of bactericidal/permeability increasing protein on endotoxic shock in conscious rabbits.
    Lin Y; Ammons WS; Leach WJ; Kung AH
    Shock; 1994 Nov; 2(5):324-31. PubMed ID: 7743357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic potential of the bactericidal/permeability-increasing protein.
    Levy O
    Expert Opin Investig Drugs; 2002 Feb; 11(2):159-67. PubMed ID: 11829710
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deficient expression of bactericidal/permeability-increasing protein in immunocompromised hosts: translational potential of replacement therapy.
    Palmer CD; Guinan EC; Levy O
    Biochem Soc Trans; 2011 Aug; 39(4):994-9. PubMed ID: 21787336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of bactericidal/permeability-increasing protein variant versus recombinant endotoxin-neutralizing protein for the treatment of Escherichia coli sepsis in rats .
    Stack AM; Saladino RA; Siber GR; Thompson C; Marra MN; Novitsky TJ; Fleisher GR
    Crit Care Med; 1997 Jan; 25(1):101-5. PubMed ID: 8989184
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein.
    von der Möhlen MA; Kimmings AN; Wedel NI; Mevissen ML; Jansen J; Friedmann N; Lorenz TJ; Nelson BJ; White ML; Bauer R
    J Infect Dis; 1995 Jul; 172(1):144-51. PubMed ID: 7797904
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of recombinant bactericidal/permeability-increasing protein (rBPI23) on neutrophil activity in burned rats.
    Hansbrough J; Tenenhaus M; Wikstrom T; Braide M; Rennekampff OH; Kiessig V; Bjursten LM
    J Trauma; 1996 Jun; 40(6):886-92; discussion 892-3. PubMed ID: 8656473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators.
    Angus DC; Birmingham MC; Balk RA; Scannon PJ; Collins D; Kruse JA; Graham DR; Dedhia HV; Homann S; MacIntyre N
    JAMA; 2000 Apr; 283(13):1723-30. PubMed ID: 10755499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protective effects of an N-terminal fragment of bactericidal/permeability-increasing protein in rodent models of gram-negative sepsis: role of bactericidal properties.
    Ammons WS; Kohn FR; Kung AH
    J Infect Dis; 1994 Dec; 170(6):1473-82. PubMed ID: 7995987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bactericidal/permeability increasing protein and host defense against gram-negative bacteria and endotoxin.
    Elsbach P; Weiss J
    Curr Opin Immunol; 1993 Feb; 5(1):103-7. PubMed ID: 8452666
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate.
    Weinrauch Y; Foreman A; Shu C; Zarember K; Levy O; Elsbach P; Weiss J
    J Clin Invest; 1995 Apr; 95(4):1916-24. PubMed ID: 7706499
    [TBL] [Abstract][Full Text] [Related]  

  • 56. rBPI23 attenuates endotoxin-induced cardiovascular depression in awake rabbits.
    Koyama S; Shibamoto T; Ammons WS; Saeki Y
    Shock; 1995 Jul; 4(1):74-8. PubMed ID: 7552782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis.
    Giroir BP; Quint PA; Barton P; Kirsch EA; Kitchen L; Goldstein B; Nelson BJ; Wedel NJ; Carroll SF; Scannon PJ
    Lancet; 1997 Nov; 350(9089):1439-43. PubMed ID: 9371168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of the bactericidal/permeability-increasing protein of polymorphonuclear leukocytes on isolated bacterial cytoplasmic membrane vesicles.
    in't Veld G; Mannion B; Weiss J; Elsbach P
    Infect Immun; 1988 May; 56(5):1203-8. PubMed ID: 3281903
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Log reduction of multidrug-resistant Gram-negative bacteria by the neutrophil-derived recombinant bactericidal/permeability-increasing protein.
    Weitz A; Spotnitz R; Collins J; Ovadia S; Iovine NM
    Int J Antimicrob Agents; 2013 Dec; 42(6):571-4. PubMed ID: 24189329
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of liver and kidney on the pharmacokinetics of a recombinant amino terminal fragment of bactericidal/permeability-increasing protein in rats.
    Bauer RJ; Der K; Ottah-Ihejeto N; Barrientos J; Kung AH
    Pharm Res; 1997 Feb; 14(2):224-9. PubMed ID: 9090714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.